Newly developed modified diluted prothrombin time reagent: A multi-centre validation in patients with non-valvular atrial fibrillation under direct oral anticoagulant therapy.
Newly developed modified diluted prothrombin time reagent: A multi-centre validation in patients with non-valvular atrial fibrillation under direct oral anticoagulant therapy.
复制标题
新开发的改良稀释凝血酶原时间试剂：对接受直接口服抗凝治疗的非瓣膜性房颤患者进行多中心验证。
DOI：
10.1016/j.thromres.2021.12.028
复制
发表时间：
2022
影响因子：
7.5
通讯作者：
Ieko M
中科院分区：
文献类型：
--
作者：
Kumano O;Suzuki S;Yamazaki M;An Y;Yasaka M;Ieko M
